Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function.
Liad HindenMajdoleen AhmadSharleen HamadAlina NemirovskiGergő SzandaSandra GlasmacherAviram Kogot-LevinRinat AbramovitchBernard ThorensJuerg GertschGil LeibowitzJoseph TamPublished in: Nature communications (2022)
Activation of the cannabinoid-1 receptor (CB 1 R) and the mammalian target of rapamycin complex 1 (mTORC1) in the renal proximal tubular cells (RPTCs) contributes to the development of diabetic kidney disease (DKD). However, the CB 1 R/mTORC1 signaling axis in the kidney has not been described yet. We show here that hyperglycemia-induced endocannabinoid/CB 1 R stimulation increased mTORC1 activity, enhancing the transcription of the facilitative glucose transporter 2 (GLUT2) and leading to the development of DKD in mice; this effect was ameliorated by specific RPTCs ablation of GLUT2. Conversely, CB 1 R maintained the normal activity of mTORC1 by preventing the cellular excess of amino acids during normoglycemia. Our findings highlight a novel molecular mechanism by which the activation of mTORC1 in RPTCs is tightly controlled by CB 1 R, either by enhancing the reabsorption of glucose and inducing kidney dysfunction in diabetes or by preventing amino acid uptake and maintaining normal kidney function in healthy conditions.